<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">According to the GLOBOCAN 2018, globally, there were 18.1 million new cancer cases and 9.6 million cancer deaths in 2018 with a speculated increasing trend in overall incidence [
 <xref ref-type="bibr" rid="CR9">9</xref>]. Cancer patients are at heightened risk for infection owing to suppressed immunity due to the malignancy per se and secondary to the effect of chemotherapy, radiotherapy and surgery. Also, reports have shown an increased rate of complications, need for ventilatory support, admission to intensive care units, overall poor prognosis and death in cancer patients with COVID-19 infection. A particular concern for a cancer surgeon is to weigh the risk of deferring cancer surgery versus the risk of COVID-19 exposure and infection to patients as well as health care providers. Disruptions in outbreak mitigation strategies like social distancing and prudent utilization of limited health resources also need consideration in this regard [
 <xref ref-type="bibr" rid="CR10">10</xref>, 
 <xref ref-type="bibr" rid="CR11">11</xref>].
</p>
